| Outgoing Relation(s) |
| lipopeptide (CHEBI:46895) is a lipid (CHEBI:18059) |
| lipopeptide (CHEBI:46895) is a peptide (CHEBI:16670) |
| Incoming Relation(s) |
| N-Ac-Asp-N6-lipoyl-KATIGFEVQEE (CHEBI:60738) is a lipopeptide (CHEBI:46895) |
| N-tetradecanoylglycylpeptide (CHEBI:17739) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-(4-bromobenzoyl)-KATIGFEVQEE (CHEBI:60225) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-(5-chloropentanoyl)-KATIGFEVQEE (CHEBI:60228) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-(6-bromohexanoyl)-KATIGFEVQEE (CHEBI:60227) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-(chloroacetyl)-KATIGFEVQEE (CHEBI:60229) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-(octanoyl)-KATIGFEVQEE (CHEBI:60230) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[(2-iodophenyl)carbonyl]-KATIGFEVQEE (CHEBI:60226) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[(2,2,2-trifluoroethoxy)acetyl]-KATIGFEVQEE (CHEBI:60231) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[(2E)-3-(m-tolyl)prop-2-enoyl]-KATIGFEVQEE (CHEBI:60236) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[(2E)-3-(3-nitrophenyl)prop-2-enoyl]-KATIGFEVQEE (CHEBI:60237) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-KATIGFEVQEE (CHEBI:60235) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[2-(trifluoromethyl)benzoyl]-KATIGFEVQEE (CHEBI:60221) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[2,5-bis(trifluoromethyl)benzoyl]-KATIGFEVQEE (CHEBI:60224) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[3-(trifluoromethyl)benzoyl]-KATIGFEVQEE (CHEBI:60222) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-[4-(trifluoromethyl)benzoyl]-KATIGFEVQEE (CHEBI:60223) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-{(2E)-3-[2-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE (CHEBI:60232) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-{(2E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE (CHEBI:60233) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-{(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE (CHEBI:60234) is a lipopeptide (CHEBI:46895) |
| Ac-Asp-N6-{3-[2-(trifluoromethyl)phenyl]propanoyl}-KATIGFEVQEE (CHEBI:60238) is a lipopeptide (CHEBI:46895) |
| aculeacin A (CHEBI:2450) is a lipopeptide (CHEBI:46895) |
| ciliatamide A (CHEBI:65630) is a lipopeptide (CHEBI:46895) |
| ciliatamide B (CHEBI:65631) is a lipopeptide (CHEBI:46895) |
| daptomycin (CHEBI:600103) is a lipopeptide (CHEBI:46895) |
| diacyl lipopeptide (CHEBI:46896) is a lipopeptide (CHEBI:46895) |
| dragomabin (CHEBI:65583) is a lipopeptide (CHEBI:46895) |
| dragonamide A (CHEBI:65584) is a lipopeptide (CHEBI:46895) |
| echinocandin (CHEBI:57248) is a lipopeptide (CHEBI:46895) |
| emericellamide (CHEBI:64372) is a lipopeptide (CHEBI:46895) |
| glycopeptidolipid (CHEBI:59375) is a lipopeptide (CHEBI:46895) |
| lipopeptide antibiotic (CHEBI:25061) is a lipopeptide (CHEBI:46895) |
| liraglutide (CHEBI:71193) is a lipopeptide (CHEBI:46895) |
| malacidin A (CHEBI:140173) is a lipopeptide (CHEBI:46895) |
| malacidin B (CHEBI:140174) is a lipopeptide (CHEBI:46895) |
| Para-LP-01 (CHEBI:77637) is a lipopeptide (CHEBI:46895) |
| polymyxin (CHEBI:59062) is a lipopeptide (CHEBI:46895) |
| semaglutide (CHEBI:167574) is a lipopeptide (CHEBI:46895) |
| syringomycin (CHEBI:32174) is a lipopeptide (CHEBI:46895) |
| triacyl lipopeptide (CHEBI:60192) is a lipopeptide (CHEBI:46895) |
